https://astx.com/wp-content/uploads/2019/11/logo_white.png00webadminhttps://astx.com/wp-content/uploads/2019/11/logo_white.pngwebadmin2009-12-11 12:30:192016-11-28 12:32:01Astex Wins Company Newsflow of the Year Award
https://astx.com/wp-content/uploads/2019/11/logo_white.png00webadminhttps://astx.com/wp-content/uploads/2019/11/logo_white.pngwebadmin2009-12-01 12:32:122016-11-28 12:32:46SuperGen Data Presentations at American Society of Hematology (ASH) Annual Meeting
https://astx.com/wp-content/uploads/2019/11/logo_white.png00webadminhttps://astx.com/wp-content/uploads/2019/11/logo_white.pngwebadmin2009-11-23 12:33:002016-11-28 12:33:21Astex Granted Orphan Drug Status for AT9283 in AML in USA and Europe
https://astx.com/wp-content/uploads/2019/11/logo_white.png00webadminhttps://astx.com/wp-content/uploads/2019/11/logo_white.pngwebadmin2009-11-12 12:33:302016-11-28 12:33:49Astex Announces Strategic Drug Discovery Alliance with GlaxoSmithKline
https://astx.com/wp-content/uploads/2019/11/logo_white.png00webadminhttps://astx.com/wp-content/uploads/2019/11/logo_white.pngwebadmin2009-11-09 11:34:452016-11-28 12:35:06Astex to disclose the structure of its HSP90 inhibitor, AT13387, at the AACR-NCI-EORTC Annual Meeting 2009
https://astx.com/wp-content/uploads/2019/11/logo_white.png00webadminhttps://astx.com/wp-content/uploads/2019/11/logo_white.pngwebadmin2009-11-03 12:35:172016-11-28 12:35:51Astex Announces a CRADA with the National Cancer Institute for its HSP90 inhibitor AT13387
https://astx.com/wp-content/uploads/2019/11/logo_white.png00webadminhttps://astx.com/wp-content/uploads/2019/11/logo_white.pngwebadmin2009-10-26 11:36:332016-11-28 12:36:57SuperGen and GSK to Collaborate on the Discovery and Development of Novel Epigenetic Therapeutics
https://astx.com/wp-content/uploads/2019/11/logo_white.png00webadminhttps://astx.com/wp-content/uploads/2019/11/logo_white.pngwebadmin2009-09-21 12:37:072016-11-28 12:37:35David Bearss Resigns as Chief Scientific Officer to Join Huntsman Cancer Institute as Co-director of Center for Investigational Therapeutics
